NDA 17702, held by Intl Medication. Lidocaine Hydrochloride.
As of Nov 14, 2026, NDA 17702 (Lidocaine Hydrochloride Preservative Free), held by Intl Medication, was first approved by FDA on Dec 20, 1976, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 1976 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Lidocaine Hydrochloride Preservative Free20% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride Preservative Free4% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Oct 18, 1995 | Supplement 25Manufacturing · Standard review | Approved | None posted |
| Oct 6, 1993 | Supplement 24Labeling · Standard review | Approved | None posted |
| May 17, 1993 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Feb 17, 1993 | Supplement 19Manufacturing · Standard review | Approved | None posted |
| Dec 14, 1992 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Dec 11, 1992 | Supplement 21Manufacturing · Standard review | Approved | None posted |
| Nov 6, 1992 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Jun 12, 1992 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| Jun 11, 1992 | Supplement 17Manufacturing · Standard review | Approved | None posted |
| Jun 26, 1986 | Supplement 10Labeling | Approved | None posted |
| Jul 11, 1978 | Supplement 4Labeling | Approved | None posted |
| Jul 11, 1978 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Aug 24, 1977 | Supplement 2Labeling | Approved | None posted |
| Aug 24, 1977 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Dec 20, 1976 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters